Related Experiment Video

Updated: May 28, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

MAP Kinases and Prostate Cancer

Gonzalo Rodríguez-Berriguete1, Benito Fraile, Pilar Martínez-Onsurbe

  • 1Department of Cell Biology and Genetics, University of Alcalá, Alcalá de Henares, 28871 Madrid, Spain.

Journal of Signal Transduction
|November 3, 2011
PubMed

Insights

Mitogen-activated protein kinase (MAPK) pathways, including ERK5, play complex roles in prostate cancer. These signaling pathways influence cell survival, death, and tumor growth, impacting treatment strategies.

Area of Science:

  • Cellular signaling and molecular biology
  • Oncology and cancer research

Background:

  • Mitogen-activated protein kinases (MAPKs) like p38, JNK, and ERK are crucial signal transducers in cellular processes.
  • While ERK is often linked to cell survival and tumor promotion, JNK and p38 are generally associated with cell death and tumor suppression.
  • Emerging evidence suggests JNK and p38 also contribute to malignancy development.

Purpose of the Study:

  • To investigate the role of MAPK pathways, including the ERK5 pathway, in prostate cancer.
  • To elucidate the involvement of these pathways as pro- or antitumor mediators.

Main Methods:

  • Focus on the effects of MAPK pathways on key cancer hallmarks.
  • Analysis of impact on apoptosis, cell survival, metastatic potential, and androgen-independent growth in prostate cancer models.

Main Results:

  • MAPK pathways exhibit dual roles in prostate cancer, acting as both pro- and antitumor mediators.
  • Specific MAPK pathways influence critical processes such as apoptosis, survival, and metastasis.
  • The less-studied ERK5 pathway's role in prostate cancer is also examined.

Conclusions:

  • MAPK signaling pathways are integral to prostate cancer progression and development.
  • Understanding the specific roles of each MAPK pathway is crucial for developing targeted therapies.
  • Further research into pathways like ERK5 may reveal novel therapeutic strategies for prostate cancer.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...